Your session is about to expire
← Back to Search
Non-Pharmacological Intervention
Brain Stimulation for Age-Related Memory Decline
N/A
Recruiting
Research Sponsored by Boston University Charles River Campus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must have no history of neurological problems or head injury
Must not be taking any psychoactive medication
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during sham intervention
Summary
This trial will explore whether age-related memory decline is due to inefficient brain activity and whether this can be improved.
Who is the study for?
This trial is for older adults aged 68-80 with normal cognitive function (as shown by specific mental exams), no psychoactive medication use, and good vision. They must not have electronic implants, metal in the head, skin sensitivity issues, depression, neurological problems or a history of head injury.
What is being tested?
The study tests if high definition transcranial electrical current stimulation can improve memory and cognition in older adults by enhancing brain activity patterns. It's non-drug based and could lead to new treatments for age-related cognitive decline.
What are the potential side effects?
Potential side effects may include discomfort at the electrode sites on the scalp, mild headaches or dizziness post-treatment. However, this technique is generally considered safe with minimal adverse effects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have never had a head injury or neurological problems.
Select...
I am not on any psychoactive medication.
Select...
My vision, with or without glasses, is normal, including seeing colors.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during active intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during active intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Memory performance speed (active stimulation condition)
Memory performance speed (sham stimulation condition)
Memory performance success (active stimulation condition)
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: active stimulationExperimental Treatment1 Intervention
Group II: sham stimulationPlacebo Group1 Intervention
Find a Location
Who is running the clinical trial?
Boston University Charles River CampusLead Sponsor
123 Previous Clinical Trials
13,487 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have never had a head injury or neurological problems.I am not on any psychoactive medication.I am between 68-80 years old, except for Experiment 1 where I am 18-30.My vision, with or without glasses, is normal, including seeing colors.
Research Study Groups:
This trial has the following groups:- Group 1: active stimulation
- Group 2: sham stimulation
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.